Conference Coverage

76-year-old male patient who underwent right lower lobectomy for lung cancer. (A) Axial image from preop DECT chest exam shows 2.3-cm part-solid nodule in right lower lobe (arrow). Nodule confirmed to represent lung adenocarcinoma, based on pathologic assessment of surgical specimen. (B) Monochromatic image at 70-KeV with color overlay shows segmentation of five pulmonary lobes. Red indicates upper lobes; yellow indicates right middle lobe; and blue indicates lower lobe. 3D volume-rendering images from (C)
News | Computed Tomography (CT)
DECT Assesses Postoperative Lung Volume, Perfusion Changes

November 7, 2022 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR) ...

Time November 07, 2022
arrow
The MEVION S250-FIT Proton Therapy System (Photo: Business Wire)
News | Proton Therapy
Mevion Identifies Site for New Compact Proton Therapy System in Development

November 3, 2022 — Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation ...

Time November 03, 2022
arrow
The FDA’s outlined framework and action plan are steps in the right direction, but we need to ensure that inaction or delayed response in addressing regulation of AI and ML do not stall innovation
Feature | Artificial Intelligence | By AJ Watson
What’s Next for AI Regulations in Medical Imaging?

After lagging other sectors for years, the era of artificial intelligence (AI) in healthcare is dawning as its use is ...

Time November 03, 2022
arrow
News | Radiation Therapy
ViewRay Launches Phase III Pancreatic Cancer Study to Demonstrate Superior Overall Survival for Patients Receiving MRI-guided Ablative Radiation Therapy

November 2, 2022 — ViewRay, Inc. announced the launch of a phase III randomized controlled trial titled "Locally ...

Time November 02, 2022
arrow
18F-rhPSMA-7.3 PET image showing prostate cancer spread beyond the prostate region (Photo courtesy of Blue Earth Diagnostics)
News | PET Imaging
Blue Earth Diagnostics Announces Results on Clinical Factors Impacting Detection Rates from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer

November 2, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time November 02, 2022
arrow
Here is a rundown of what you and your colleagues found to be most interesting in the field of medical imaging during the month of October including #COVID-19 coverage
Feature | Radiology Business | By Melinda Taschetta-Millane
Top 10: Content that Caught Your Eye in October

Here is a rundown of what you and your colleagues found to be most interesting in the field of medical imaging during ...

Time November 01, 2022
arrow
The collaborative HIMSS-SIIM Enterprise Imaging Workgroup defines enterprise imaging as “a set of strategies, initiatives and workflows implemented across a healthcare enterprise to consistently and optimally capture, index, manage, store, distribute, view, exchange, and analyze all clinical imaging and multimedia content to enhance the electronic health record.”
Feature | Enterprise Imaging | By Melinda Taschetta-Millane
Enterprise Imaging: 2022 in Review

The collaborative HIMSS-SIIM Enterprise Imaging Workgroup defines enterprise imaging as “a set of strategies ...

Time November 01, 2022
arrow
First experience of proton Flash therapy in the clinic appears promising for future clinical trials
News | Proton Therapy
Varian and the Cincinnati Children's/University of Cincinnati Medical Center Proton Therapy Center Announce Promising Results from FAST-01, First-in-Human Clinical Trial of Flash Therapy

October 31, 2022 — Varian, a Siemens Healthineers company, and the Cincinnati Children's/University of Cincinnati ...

Time October 31, 2022
arrow
News | ASTRO | By Christine Book
“Cancer Breakthroughs” Session at ASTRO2022 Unveils Key Findings from ASCO, AAPM

October 31, 2022 — During the highly-anticipated “Cancer Breakthroughs” session at ASTRO2022, incoming ASTRO President ...

Time October 31, 2022
arrow
Screenshot of communication and tracking tool for radiologist-recommended follow-up imaging
News | PACS
PACS, EHR Tool Identifies Incomplete, Clinically Necessary Follow-up Imaging

October 28, 2022 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR) ...

Time October 28, 2022
arrow
Chad Tang, MD
News | Prostate Cancer
Metastasis-Directed Radiation Therapy Plus Hormone Therapy Improves Progression-Free Survival for Men with Advanced Prostate Cancer

October 27, 2022 — Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding ...

Time October 27, 2022
arrow
CIVCO Radiotherapy has announced it is joining forces with Qfix, which provides patient positioning and immobilization devices.
News | ASTRO
CIVCO Radiotherapy Announces Integration with Qfix

October 26, 2022 — CIVCO Radiotherapy, a global provider of radiotherapy solutions, has announced it is joining forces ...

Time October 26, 2022
arrow
The oral presentation includes additional results from Blue Earth's Phase 3 SPOTLIGHT study evaluating the impact of clinical factors on the detection rate of 18F-rhPSMA-7.3 PET imaging in men with suspected prostate cancer recurrence based on elevated PSA following prior therapy
News | PET Imaging
Blue Earth Diagnostics Highlights Presentations on Axumin (Fluciclovine F 18) and Investigational 18F-rhPSMA-7.3 in Biochemically Recurrent Prostate Cancer

October 25, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time October 25, 2022
arrow
Healthcare providers able to enhance clinical operations through specialized services for advanced radiation therapy solutions
News | Radiation Oncology
Elekta Increases Value-Added Services and Strengthens its Position as a Life-Time Companion

October 25, 2022 — In order to provide improved efficiency and expertise to its customers, Elekta (EKTA-B.ST) announces ...

Time October 25, 2022
arrow
RaySearch Laboratories AB (publ) will be showcasing the latest oncology software innovations at ASTRO 2022
News | Radiation Oncology
Latest Innovations in RayStation, RayCare and RayIntelligence to be Presented at ASTRO 2022

October 25, 2022 — RaySearch Laboratories AB (publ) will be showcasing the latest oncology software innovations at ASTRO ...

Time October 25, 2022
arrow
Randomized trial also finds addition of local treatment could offer patients more time off hormone therapy
News | Prostate Cancer
Radiation-hormone Therapy Combination May Slow Growth of Oligometastatic Prostate Cancer

October 25, 2022 — A new study offers a new option to patients with oligometastatic prostate cancer who want relief from ...

Time October 25, 2022
arrow
Introducing the TotalRT All in One Solution to Quickly Adapt CIVCO RT's Radiotherapy Solutions
News | Radiation Therapy
CIVCO Radiotherapy to Exhibit Most Recent Innovations at ASTRO Annual Meeting

October 24, 2022 — CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric ...

Time October 24, 2022
arrow
Company announces SCINTIX as new product name for its flagship biology-guided radiotherapy technology
News | PET-CT
RefleXion Highlights New Cancer Treatment Research Abstracts for Presentation at ASTRO 2022

October 24, 2022 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a ...

Time October 24, 2022
arrow
The MEVION S250-FIT Proton Therapy System (Photo: Business Wire)
News | Proton Therapy
Mevion Introduces New MEVION S250-FIT Proton Therapy System

October 24, 2022 — Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation ...

Time October 24, 2022
arrow
Randomized trial finds hypofractionated whole-breast radiation with concurrent boost comparable to six weeks of treatment for patients with higher-risk disease
News | Breast Imaging
Three-week Course of Radiation Safe and Effective for Patients with Early-stage Breast Cancer and Elevated Risk of Recurrence

October 24, 2022 — A three-week course of radiation therapy is as safe and effective as four to six weeks of treatment ...

Time October 24, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now